Allevion Therapeutics has filed a notice of an exempt offering of securities to raise $1,475,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Allevion Therapeutics is raising up to $1,475,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shawn Moaddeb played a…